Severe hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro

被引:42
作者
Schaub, N [1 ]
Bircher, AJ [1 ]
机构
[1] Univ Basel Hosp, Dept Dermatol, Allergy Unit, CH-4031 Basel, Switzerland
关键词
anticonvulsant; drug interaction; hypersensitivity syndrome; lamotrigine; lymphocyte stimulation test; risk factors; sodium valproate;
D O I
10.1034/j.1398-9995.2000.00467.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: The anticonvulsant lamotrigine has been associated with severe adverse events such as the hypersensitivity syndrome and severe bullous reactions. So far, specific immunologic tests have rarely been performed to demonstrate specific sensitization. Methods: A 36-year-old man suffering from epilepsy was concomitantly treated with high doses of sodium valproate and lamotrigine. About 1 month later, a severe hypersensitivity syndrome occurred affecting skin, lymph nodes, and liver. Three months later, skin tests and lymphocyte stimulation tests with anticonvulsants were performed. Results: Skin tests were negative with all drugs; lymphocyte stimulation tests were twice positive with lamotrigine. Later re-exposure to sodium valproate was tolerated. Conclusions: Lamotrigine may elicit a severe hypersensitivity syndrome. Particularly high initial doses and concomitant treatment with sodium valproate increase the risk of cutaneous reactions. The lymphocyte stimulation test was used to identify the culprit drug. Lymphocyte sensitization to the drug or a metabolite may be involved in the pathogenesis.
引用
收藏
页码:191 / 193
页数:3
相关论文
共 17 条
[1]  
BIRCHER AJ, 1995, CURR PROBL DERMATOL, V22, P31
[2]   Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS) [J].
Bocquet, H ;
Bagot, M ;
Roujeau, JC .
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 1996, 15 (04) :250-257
[3]   Hypersensitivity reaction in a child due to lamotrigine [J].
Brown, TS ;
Appel, JE ;
Kasteler, JS ;
Callen, JP .
PEDIATRIC DERMATOLOGY, 1999, 16 (01) :46-49
[4]  
Buzan RD, 1998, J CLIN PSYCHIAT, V59, P87
[5]   Hypersensitivity syndrome due to 2 anticonvulsant drugs [J].
Conilleau, V ;
Dompmartin, A ;
Verneuil, L ;
Michel, M ;
Leroy, D .
CONTACT DERMATITIS, 1999, 41 (03) :141-144
[6]   Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome [J].
Descamps, V ;
Bouscarat, F ;
Laglenne, S ;
Aslangul, E ;
Veber, B ;
Descamps, D ;
Saraux, JL ;
Grange, MJ ;
Grossin, M ;
Navratil, E ;
Crickx, B ;
Belaich, S .
BRITISH JOURNAL OF DERMATOLOGY, 1997, 137 (04) :605-608
[7]  
ELWOOD W, 1998, REACTIONS, V7, P3
[8]   LAMOTRIGINE - AN UPDATE OF ITS PHARMACOLOGY AND THERAPEUTIC USE IN EPILEPSY [J].
FITTON, A ;
GOA, KL .
DRUGS, 1995, 50 (04) :691-713
[9]   Lamotrigine hypersensitivity in childhood epilepsy [J].
Iannetti, P ;
Raucci, U ;
Zuccaro, P ;
Pacifici, R .
EPILEPSIA, 1998, 39 (05) :502-507
[10]   Safety of long-term lamotrigine in epilepsy [J].
Mackay, FJ ;
Wilton, LV ;
Pearce, GL ;
Freemantle, SN ;
Mann, RD .
EPILEPSIA, 1997, 38 (08) :881-886